Status:
TERMINATED
A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)
Lead Sponsor:
Alza Corporation, DE, USA
Conditions:
Pain
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to document the use of fentanyl HCl 40 mcg system under routine conditions and obtain a more comprehensive understanding of the safety of the system and complications that ...
Detailed Description
The safety of fentanyl HCl 40 mcg system has been evaluated in a number of research studies. Although this research included patients with acute moderate to severe pain after particular types of surge...
Eligibility Criteria
Inclusion
- Adult patients
- Planned surgery
- Planned use of fentanyl HCl 40 mcg system or IV Patient-Controlled Analgesia opioid treatment for postoperative pain
Exclusion
- \- Pain resulting from emergency surgery
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT00665522
Start Date
December 1 2007
End Date
September 1 2008
Last Update
April 10 2015
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Feldkirch, Austria
2
Graz, Austria
3
Klagenfurt, Austria
4
Linz, Austria